会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 24. 发明申请
    • OLIGOMER ARRAY WITH PNA AND/OR DNA OLIGOMERS ON A SURFACE
    • 具有PNA和/或DNA寡核苷酸的寡核苷酸阵列在表面上
    • WO0138565A3
    • 2001-11-15
    • PCT/DE0004301
    • 2000-11-24
    • EPIGENOMICS AGBERLIN KURT
    • BERLIN KURT
    • C12N15/09C12Q1/68
    • C12Q1/6827C12Q1/6837C12Q2523/125
    • The invention relates to an oligomer array with PNA (Peptide Nucleic Acid) and/or DNA oligomers on a surface, said oligomers comprising oligomers of 6 to 20 monomers or nucleobases each. Said monomers or nucleobases comprise at least one sequence of the general formula DDCGDD or of the general formula DDTGDD or of the general formula HHCGHH or of the general formula HHCAHH, wherein H represents any of the bases adenine (A), cytosine (C) or thymine (T) and D represents any of the bases adenine (A), guanine (G) or thymine (T). The location of the oligomers on the surface is correlated with the sequence of the oligomers. The inventive oligomer arrays are used to detect cytosine methylations in genomic DNA.
    • 公开的是与PNA(肽核酸)的低聚物阵列 - 和/或DNA寡聚体的表面上,包括单体或核碱基6和20之间的低聚物,其中,所述通式或一般DDCGDD中的至少一个序列 式DDTGDD或通式HHCGHH或通式HHCAHH包括wobeiH的碱基腺嘌呤(A),胞嘧啶(C)或胸腺嘧啶(T)的装置之一和D的碱基腺嘌呤(A),鸟嘌呤(G)或胸腺嘧啶的一个(T )基团,并且其中,所述的低聚物与所述低聚物的序列的表面上的位点相关。本发明Oligomar阵列在基因组DNA用于检测甲基化胞嘧啶的。
    • 28. 发明申请
    • METHODS AND COMPOSITIONS FOR DIFFERENTIATING TISSUES OR CELL TYPES USING EPIGENETIC MARKERS
    • 使用染色体标记分化组织或细胞类型的方法和组合物
    • WO2005019477A3
    • 2005-06-16
    • PCT/US2004026071
    • 2004-08-12
    • EPIGENOMICS AGLEWIN JOERNBERLIN KURTHILDMANN THOMASOLEK ALEXANDERBECK STEPHANNOVIK KAREN
    • LEWIN JOERNBERLIN KURTHILDMANN THOMASOLEK ALEXANDERBECK STEPHANNOVIK KAREN
    • C12Q1/68
    • C12Q1/6881C12Q2600/154C12Q2600/16
    • The present invention provides, inter alia, a method for generating a genome-wide epigenomic map, comprising a correlation between methylation variable CpG positions (MVP) and genomic DNA sample types. MVP are those CpG positions that show a variable quantitative level of methylation between sample types. Particular genomic regions of interest (ROI) provide preferred marker sequences that comprise multiple, and preferably proximate MVP, and that have novel utility for distinguishing sample types. The epigenic maps have broad utility, for example, in identifying sample types, or for distinguishing between and among sample types. In a preferred embodiment the epigenomic map is based on methylation variable regions (MVP) within the major histocompatibility complex (MHC), and has utility, for example, in identifying the cell or tissue source of a genomic DNA sample, or for distinguishing one or more particular cell or tissue types among other cell or tissue types. Analysis of epigenetic characteristics of one, or of a set of nucleic acid sequences, in the context of an inventive epigenomic map, allows for the determination of an origin of the nucleic acids.
    • 本发明尤其提供了一种生成全基因组表观遗传学图谱的方法,其包括甲基化可变CpG位点(MVP)和基因组DNA样品类型之间的相关性。 MVP是显示样品类型之间甲基化可变定量水平的那些CpG位置。 特定的感兴趣的基因组区域(ROI)提供优选的标记序列,其包含多个,优选接近MVP,并且具有用于区分样品类型的新颖效用。 表征性地图具有广泛的用途,例如,在识别样本类型中,或用于区分样本类型和样本类型。 在优选的实施方案中,表观基因组图基于主要组织相容性复合物(MHC)内的甲基化可变区(MVP),并且可用于例如鉴定基因组DNA样品的细胞或组织来源,或用于区分一个或 更特定的细胞或组织类型与其他细胞或组织类型。 在本发明表观遗传学图谱的背景下,一种或一组核酸序列的表观遗传学特征的分析允许确定核酸的来源。